Assembly Biosciences, Inc. (ASMB)

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	19.21	19.84	52.42	45.63	59.44	46.73
Short-Term Investments	90.01	110.41	39.19	101	156.97	227.31
Cash & Short-Term Investments	109.22	130.25	91.61	146.63	216.41	274.04
Cash Growth	82.55%	42.18%	-37.52%	-32.25%	-21.03%	25.66%
Accounts Receivable	-	0.04	0.94	0.34	1.23	3.37
Other Receivables	0.4	0.3	0.3	-	-	-
Receivables	0.4	0.34	1.24	0.34	1.23	3.37
Prepaid Expenses	3.31	3.2	4.11	7.24	6.85	5.36
Total Current Assets	112.93	133.79	96.97	154.2	224.49	282.78
Property, Plant & Equipment	2.08	2.72	3.94	7.18	10.73	13.81
Long-Term Investments	-	-	-	27.97	-	-
Goodwill	-	-	-	-	12.64	12.64
Other Intangible Assets	-	-	-	-	29	29
Long-Term Deferred Charges	-	-	0.2	0.2	0.8	-
Other Long-Term Assets	0.31	0.31	0.69	1.5	5.59	1.68
Total Assets	115.32	136.82	101.79	191.06	283.25	339.91
Accounts Payable	0.8	0.46	2.49	2.66	4.6	1.73
Accrued Expenses	6.12	6.63	9.84	10.26	12.27	11.02
Current Portion of Leases	1.3	1.22	3.36	3.15	3.4	3.19
Current Unearned Revenue	33.06	30.92	-	-	-	6.41
Other Current Liabilities	-	-	0.6	-	4.16	2.09
Total Current Liabilities	41.27	39.23	16.3	16.07	24.43	24.44
Long-Term Leases	0.45	1.12	0.1	3.33	6.73	9.08
Long-Term Unearned Revenue	38.92	55.38	2.73	2.73	8.99	30.64
Long-Term Deferred Tax Liabilities	-	-	-	-	2.53	2.53
Total Liabilities	80.64	95.73	19.13	22.13	42.68	66.69
Common Stock	0.01	0.01	0	0.05	0.03	0.03
Additional Paid-In Capital	840.95	826.92	807.98	800.73	742.39	712.81
Retained Earnings	-805.98	-785.75	-724.52	-631.43	-501.57	-439.42
Comprensive Income & Other	-0.29	-0.08	-0.8	-0.42	-0.27	-0.2
Total Common Equity	34.68	41.1	82.66	168.93	240.58	273.22
Shareholders' Equity	34.68	41.1	82.66	168.93	240.58	273.22
Total Liabilities & Equity	115.32	136.82	101.79	191.06	283.25	339.91
Total Debt	1.75	2.34	3.47	6.48	10.13	12.27
Net Cash (Debt)	107.47	127.91	88.15	168.12	206.28	261.78
Net Cash Growth	85.09%	45.11%	-47.57%	-18.50%	-21.20%	20.04%
Net Cash Per Share	20.64	27.94	21.85	46.61	69.87	119.63
Filing Date Shares Outstanding	6.35	5.48	4.33	4.01	3.19	2.72
Total Common Shares Outstanding	6.35	5.48	4.07	4.01	2.84	2.71
Working Capital	71.66	94.56	80.67	138.13	200.06	258.34
Book Value Per Share	5.47	7.50	20.29	42.13	84.84	100.70
Tangible Book Value	34.68	41.1	82.66	168.93	198.94	231.58
Tangible Book Value Per Share	5.47	7.50	20.29	42.13	70.16	85.35
Machinery	-	0.53	0.8	0.72	0.95	0.95
Leasehold Improvements	-	0.06	1.63	1.63	2.49	2.08

Source: S&P Capital IQ. Standard template. Financial Sources.